Category: New York Times

  • This Is What Transgender Eradication Looks Like

    This Is What Transgender Eradication Looks Like

    Rating: Transsupportive, Erin in the Morning, August 23, 2023 (PDF archive) (HTML archive) (Take Action) Action Recommendations Content Summary This Is What Transgender Eradication Looks Like   On Monday morning, we learned of a tragic incident: a woman was fatally attacked outside her store by an individual who had torn down the pride flag displayed…

  • Russia’s Law Targeting Transgender People Sows Fear for L.G.B.T. Russians

    Russia’s Law Targeting Transgender People Sows Fear for L.G.B.T. Russians

    Rating: Trans supportive neutral phobic, New York Times, August 1, 2023 (PDF archive) (HTML archive) Content Summary Russia’s Law Targeting Transgender People Sows Fear for L.G.B.T. Russians A new law underscores how Vladimir V. Putin is increasingly using the war in Ukraine as justification for greater restrictions on L.G.B.T.Q. life, portraying it as a consequence…

  • GenderMenace.net Media Rankings for June 2023

    GenderMenace.net Media Rankings for June 2023

    Here at GenderMenace.net, we review a lot of media stories that address gender issues each month. For each story, we provide a rating of “Transsupportive”, “Transneutral”, or “Transphobic”. These labels make it possible to perform an article count for each media source that gives a sense of how to rank them from most transsupportive to…

  • He’s The Trans Son Of An Anti-Trans Influencer. It’s His Turn To Speak.

    He’s The Trans Son Of An Anti-Trans Influencer. It’s His Turn To Speak.

    Renton Sinclair’s mother is a former Miss Illinois who wants to force trans people out of public life. That’s exactly what makes her a rising star in MAGA World. Rating: Transsupportive, Huffington Post, June 30, 2023 (PDF archive) (HTML archive) (Video archive)

  • Britain Limits Use of Puberty-Blocking Drugs to Research Only

    Britain Limits Use of Puberty-Blocking Drugs to Research Only

    Britain’s National Health Service announced on Friday that it would limit the use of puberty-suppressing drugs to children enrolled in clinical trials. The change comes as the agency’s pediatric gender services have struggled to keep up with soaring demand. Rating: Transneutral, New York Times, June 9, 2023 (PDF archive)